FDA Inspection 1239947 — Mark V. DiBuono, MD

Mark V. DiBuono, MD — FEI 3007159391

The FDA completed an inspection of Mark V. DiBuono, MD on May 31, 2024 in Staten Island, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 31, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Staten Island, NY (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance